Stock ATXI AVENUE THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

News Chart Avenue Therapeutics, Inc.

Equities

ATXI

US05360L4032

Market Closed - Nasdaq
Other stock markets
 16:00:00 2024-05-31 EDT 		5-day change 1st Jan Change
3.44 USD -4.71% Intraday chart for Avenue Therapeutics, Inc. -4.97% -71.51%
05-16 Avenue Therapeutics, Inc Announces Last Patient Last Visit in Phase 1b/2a Clinical Trial of AJ201 for the Treatment of Spinal and Bulbar Muscular Atrophy (Kennedy's Disease) CI
05-15 Avenue Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
22bc67190.iBZwcB4qUC2wO9oJs_4pvs7dqft7w8WEoMbPG7jXvIs.7UAhOkhQNWvSXLlE_K1K5vqq4Ko_u_zL1ZKrKvXkj-bwWEUGLVomfdJegw~fac67ca281e8118640f2438d855d4302
  1. Stock Market
  2. Equities
  3. ATXI Stock
  4. Charts Avenue Therapeutics, Inc.
  5. News Chart